Sab Biotherapeutics Inc. (SABS)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
3. 54
-0.12
-3.4106%
$
34.41M Market Cap
0.1 P/E Ratio
- Div Yield
678,400 Volume
0 Eps
$ 3.67
Previous Close 
Want to track SABS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sab Biotherapeutics Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Eliana Merle Barclays | 483.23 | $1,855.61 | $1,763.79 | -$91.82 | -4.95% |
| RS Roger Song Jefferies | 4,397.54 | $15,962.16 | $15,919.09 | -$43.07 | -0.27% |
| EW Edward White HC Wainwright & Co. | -141,296.67 | $353,241.68 | $511,493.95 | -$158,252.27 | -44.8% |
| EB Emily Bodnar HC Wainwright & Co. | 2,125.85 | $8,226.21 | $7,695.58 | -$530.63 | -6.45% |
